Publication
Number of items: 9.
20 December 2024
  • Accelerating in translation: enhancing clinical and preclinical recovery from treatment-resistant depression with accelerated neuromodulation protocols. (2024) M. Boffa, G. d’Andrea, L. De Risio, S. Spalletti, V. Zecca, C. Cerri, M. Bertone, T. Singh, G. Palombelli, C. Cavallotto, E. Výborová, L.P. Padula, I. Rosa, R. Canese, G. Di Lorenzo, E. Pompili, G. Nicolò, S.L. Sensi, G. Martinotti and F. Zoratto
  • Neuromodulation in a preclinical model of treatment-resistant depression: neurobehavioural effects of a standard protocol. (2024) M. Boffa, F. Martella, S. Spalletti, L. De Risio, G. Di Lorenzo, S.L. Sensi, G. Martinotti, C. D'Addario, M. Pettorruso and F. Zoratto
  • Participation in an Italian cancer screening program among people with psychiatric diagnoses: a retrospective cohort study. (2024) S. Burato, A. D'Aietti, A. Paci, L. Pellegrini, C. Sindici, C. Dellach, S. Negro and U. Albert
  • Event-related potentials correlate with magnetic resonance spectroscopy measures of excitatory neurotransmission and symptom severity in obsessive-compulsive disorder. (2024) A.M. Frota Lisboa Pereira De Souza, Marjan Biria, P. Banca, N.A. Fineberg and T.W. Robbins
  • Meta-analysis of duration of untreated illness in obsessive-compulsive disorder: the need for early interventions. (2024) L. Pellegrini, S. Burato, S. Giobelli, G. Maina, N. Fineberg and U. Albert
  • 23 May 2024
  • Cognitive inflexibility, obsessive-compulsive symptoms and traits and poor post-pandemic adjustment. (2024) Ana Maria Frota Lisboa Pereira De Souza, Luca Pellegrini and Naomi Fineberg
  • 15 February 2024
  • Subjective fatigue in individuals with anxiety and mood disorders correlates with specific traits of obsessive-compulsive personality disorder. (2024) Agne Stanyte, Naomi A. Fineberg, Aurelija Podlipskyte, Julija Gecaite-Stonciene and Julius Burkauskas
  • 26 December 2023
  • Smartphone app-induced habit: a therapeutic component in psychological treatment for obsessive-compulsive disorder. (2023) A.M. Frota Lisboa Pereira De Souza, P. Banca, T. Robbins, D. Wellstead, D. Mpavaenda and N. Fineberg
  • Selective serotonin reuptake inhibitors (SSRIs) may improve behavioral inhibition in patients with obsessive compulsive disorder: a feasibility study. (2023) L. Pellegrini, R. Jemma, D. Wellsted and N. Fineberg